Cancer Control and Population Sciences In the News
The National Cancer Institute awarded a grant to City of Hope with the goal of sparking passion for science among underrepresented minority youth in neighboring communities. YES2SUCCESS comprises a pipeline of outreach activities and hands-on participation in research from sixth grade through the undergraduate years.
The National Academy of Medicine (NAM) today announced the election of 90 regular members and 10 international members during its annual meeting. Betty Ferrell is among the list.
A National Institutes of Health-funded study led by City of Hope’s Stacy Gray, M.D., examined a person’s emotional state before they received test results and after. Researchers found that anxiety and depression did not increase significantly following genetic test result disclosure.
City of Hope researcher Susan Neuhausen, Ph.D., is studying genomic breast cancer risk among Latinas. The research is vital, as Latinas are underrepresented in studies of breast cancer and genetic risk assessment.
The End-of-Life Nursing Education Consortium (ELNEC) curricula developed by City of Hope nurses is now available and has been shared in its 100th country, Bulgaria.
Where in the early days of the HIV epidemic the idea of stem cell transplants for HIV patients with cancer was considered crazy, the procedure is now commonly performed.
City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research annual meeting from March 29 through April 3 in Atlanta.
City of Hope will showcase ongoing studies and data on chimeric antigen receptor (CAR) T cell therapy, immunotherapy against solid tumors and more at the American Association for Cancer Research (AACR) annual meeting from March 29 through April 3 in Atlanta.
City of Hope scientist, Rick Kittles, Ph.D., and his colleagues found that some commercial cell lines used for countless laboratory studies have mislabeled ancestry when it comes to minorities.
As the biomedical field races to develop therapies based on an individual’s genetic makeup, a City of Hope scientist and his colleagues found that some commercial cell lines used for countless laboratory studies have mislabeled ancestry when it comes to minorities.
If you've thought about trying one of those home DNA kits, think before you spit. Even the most elaborate home test only scratches the surface.
Dealing with air pollution is a fact of life in many California cities. Learn how it impacts your health and what you can do about it.
The overall cancer death rate has dropped by 27 percent over the last 25 years, according to data released last week by the American Cancer Society. City of Hope's James Lacey, Ph.D., M.P.H., breaks down the results.
William Dale, M.D., Ph.D., has been named the Arthur M. Coppola Family Chair in Supportive Care Medicine in recognition of his 20 years of work helping patients and their families make informed medical decisions that improve quality of life.
At 14, City of Hope patient Nicole Schulz was a girl on the go, and even acute myeloid leukemia couldn’t stop her. Now she's facing a new challenge - the side effects of her lifesaving treatment.
When Little League pitcher Jaylon Fong was 8, he was stricken with leukemia. At 12, he was finally declared cancer-free, only to relapse months later. But for him, cancer's just another opponent to beat.
The Journal of the American Medical Association Oncology invited City of Hope’s Victoria Seewaldt, M.D., to provide her expert commentary on two studies published today about ovarian and hepatocellular cancer prevention.
Patients with metastatic kidney cancer who have high rates of distress tend to have poorer overall survival compared to those with low distress, according to a new study by City of Hope researchers.
The Dr. Norman and Melinda Payson Professorships recognize City of Hope clinicians and researchers who have contributed greatly to biomedical research.
A new electronic monitor called Vivio, developed by Caltech with City of Hope, promises to make cardiac screening easier and more accessible for cancer patients and physicians.